Clinical profile and outcome of non-COVID strokes during pandemic and the pre pandemic period: COVID-Stroke Study Group (CSSG) India

Autor: Vivek Nambiar, Sathish Parkipandla, Rajsrinivas Parthasarathy, Praveen Panicker, S Kumaravelu, Rajeshwar Sahonta, Rohit Bhatia, Kamal Kajal, Girish Baburao Kulkarni, Vijaya Pamidimukkala, Manshi Kashyap, Githin Benoy George, A V R Taallapalli, Dheeraj Khurana, Ajay Garg, P N Sylaja, Thomas Iype, Rakesh Singh, Hiral Halani, Ayush Agarwal, Ashish Duggal, Nirendra Rai, Sritheja Reddy, Salil Gupta, Vipul Gupta, Roopa Rajan, Shailesh Gaikwad, Anu Gupta, Sapna Erat Sreedharan, P M Yogeesh, Snigdha Komakula, Leve Joseph, Vivek Lal, Arvind Sharma, M V Padma Srivastava, Prashant Dixit, Ashish Datt Upadhyay, Mamta Singh, Pranjal Gupta, Debashish Chowdhury, Sucharita Ray, Jayanta Roy, Vibhor Pardasani, Mamta Parmar, Vamsi Chalasani, Deepti Vibha, Suman Kushwaha, Krishna Sreela, Rajshekar Reddy, Harsh Oza, Biswamohan Misra, Chirag Kamal Ahuja, Sudheer Pachipala, A.K. Pandit, Jeyaraj D Pandian, Srinivasareddy Sanivarapu, Srijithesh P. Rajendran, Manish Salunkhe, Venugopalan Y Vishnu, M K Suresh, Vikas Suri, Dileep Ramachandran
Jazyk: angličtina
Rok vydání: 2021
Předmět:
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
rTPA
Recombinant Tissue Plasminogen Activator
medicine.medical_treatment
CVT
Cerebral Venous Thrombosis
CSSG
COVID-19 Stroke Study Group
India
Stroke care
Article
Time-to-Treatment
TNK
Tenecteplase
Pandemic
medicine
Humans
Endovascular treatment
Stroke
Pandemics
Retrospective Studies
COVID-19
Coronavirus disease 2019
Ischemic stroke
RTPCR
Real Time Polymerase Chain Reaction
business.industry
SARS-CoV-2
NIHSS
National Institutes of Health Stroke Scale
COVID-19
mRS
modified Rankin score
Retrospective cohort study
Thrombolysis
CT
Computed Tomography
SD
Standard Deviation
ICH
Intracerebral Hemorrhage
medicine.disease
Door to needle time
Neurology
Emergency medicine
Communicable Disease Control
EVT
Endovascular Therapy
IQR
Inter-quartile range
LVO
Large Vessel Occlusion
Neurology (clinical)
ASPECTS
Alberta stroke program early CT score
business
Zdroj: Journal of the Neurological Sciences
ISSN: 1878-5883
0022-510X
Popis: Background As the health systems around the world struggled to meet the challenges of COVID-19 pandemic, care of many non-COVID emergencies was affected. Aims The present study examined differences in the diagnosis, evaluation and management of stroke patients during a defined period in the ongoing pandemic in 2020 when compared to a similar epoch in year 2019. Methods The COVID stroke study group (CSSG) India, included 18 stroke centres spread across the country. Data was collected prospectively between February and July 2020 and retrospectively for the same period in 2019. Details of demographics, stroke evaluation, treatment, in-hospital and three months outcomes were collected and compared between these two time points. Results A total of 2549 patients were seen in both study periods; 1237 patients (48.53%) in 2019 and 1312 (51.47%) in 2020. Although the overall number of stroke patients and rates of thrombolysis were comparable, a significant decline was observed in the month of April 2020, during the initial period of the pandemic and lockdown. Endovascular treatment reduced significantly and longer door to needle and CT to needle times were observed in 2020. Although mortality was higher in 2020, proportion of patients with good outcome were similar in both the study periods. Conclusions Although stroke admissions and rates of thrombolysis were comparable, some work flow metrics were delayed, endovascular stroke treatment rates declined and mortality was higher during the pandemic study period. Reorganization of stroke treatment pathways during the pandemic has likely improved the stroke care delivery across the globe.
Databáze: OpenAIRE
Externí odkaz: